Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection

Table 2 Effect of six months treatment with HD-03/ES on liver function tests (mean ± SD)

Parameter	d 0	Four months	Six months
Alanine aminotransferase (ALT) (IU/L)	66.5 ± 11.1	41.6 ± 05.1	39.1 ± 5.2
Aspartate aminotransferase (AST) (IU/L)	47.5 ± 9.5	42.4 ± 10.7	40.2 ± 10.1
Serum albumin (g%)	3.5 ± 0.8	3.5 ± 0.7	3.6 ± 0.7
Serum globulin (g%)	2.9 ± 0.3	3.1 ± 0.2	3.2 ± 0.2
Total protein (g%)	6.2 ± 0.7	6.5 ± 0.7	6.5 ± 0.7
Serum bilirubin (mg%)	1.3 ± 0.6	1.2 ± 0.5	1.1 ± 0.5
Alkaline phosphatase (IU/L)	155.5 ± 9.8	140.2 ± 9.0	127.0 ± 7.5